Imunon (IMNN) Preferred Dividend Payments (2013 - 2017)

Imunon's (IMNN) quarterly Preferred Dividend Payments came in at -$345685.0 in Q2 2017, down 107.51% on a QoQ basis from $4.6 million in Q1 2013.

Imunon (IMNN) Preferred Dividend Payments (2013 - 2017) Analysis & Trends

Imunon (IMNN) has 2 years of Preferred Dividend Payments data on file, last reported at -$345685.0 in Q2 2017.

Quarterly Preferred Dividend Payments changed N/A year-over-year to -$345685.0 in Q2 2017, while the trailing twelve-month figure through Dec 2017 was -$345685.0 (changed N/A YoY) and the FY2017 annual result came in at -$345685.0, changed N/A from the prior year.
Preferred Dividend Payments slipped to -$345685.0 in Q2 2017, from $4.6 million in the prior quarter.
In the past five years, Preferred Dividend Payments ranged from a high of $4.6 million in Q1 2013 to a low of -$345685.0 in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Imunon	8.42 Mn	8.42 Mn	-	-

Download Data

Date	Value
Jun 30, 2017	-345,685.00
Mar 31, 2013	4.60 Mn